Study: Many cancer drugs unproven 5 years after accelerated approval
Time:2024-05-21 16:51:06 Source:entertainmentViews(143)
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Previous:Hollywood star Shia LaBeouf is spotted on the streets of Gavin and Stacey's hometown Barry
Next:Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
You may also like
- Nadal returns to Roland Garros to practice amid doubts over fitness and form
- China unveils regulations on implementation of consumer rights protection law
- Scheana Shay rubs Lala Kent's swimsuit
- 'Love in Nanning' concert unites singles for a romantic evening
- 'Constantly learning' Imanaga off to impressive start with the Chicago Cubs
- 'Love in Nanning' concert unites singles for a romantic evening
- Kirill Kaprizov helps Wild end Kings' eight
- CPC to implement Party discipline education campaign
- Tom Brady and Jay